ABSTRACT
OBJECTIVE: To investigate the variations in clinical effectiveness among patients diagnosed with knee osteoarthritis who underwent intra-articular administration of platelet-rich plasma using single, triple, or quintuple injections. METHODS: One hundred twenty patients with grade I-III knee osteoarthritis were randomly assigned to three groups: PRP1 group, who received a single injection of platelet-rich plasma; PRP3 group, who received three PRP injections one week apart; PRP5 group, who received five PRP injections one week apart. The patients' conditions were evaluated using the Visual Analogue Scale (VAS) and the Western Ontario and McMaster Universities Arthritis Index-VA3.1 version (WOMAC-VA3.1) at baseline and 6, 12, 24, and 52 weeks 52 weeks follow up. RESULTS: Out of the total participants, 106 patients (30 males and 76 females) completed the study. The primary outcome measure, WOMAC pain score, registered significant improvements across all groups when compared to pre-treatment levels. However, the application of 3 and 5 injections of platelet-rich plasma was substantially more effective than that of a single injection in reducing knee pain and stiffness, as well as enhancing physical function in patients with knee osteoarthritis. No statistically discernable difference was observed between PRP3 and PRP5 at all follow-up intervals, and there was no discernable difference between 3 and 5 PRP injections either. Mild side effects occurred in all three groups. CONCLUSIONS: The administration of three or five injections of platelet-rich plasma is safe, substantially more effective than single injections, and leads to remarkable clinical improvement by significantly reducing knee pain, improving joint stiffness, and enhancing physical function in patients with grade I-III knee osteoarthritis. Furthermore, no significant difference was observed in the efficacy of three or five injections. Therefore, we recommend using three injections of PRP in the treatment of patients with knee osteoarthritis of grade I-III.
Subject(s)
Osteoarthritis, Knee , Platelet-Rich Plasma , Humans , Osteoarthritis, Knee/therapy , Injections, Intra-Articular , Female , Male , Middle Aged , Treatment Outcome , Aged , Pain Measurement , Follow-Up StudiesABSTRACT
Objective: Observe the effects of platelet-rich plasma (PRP) therapy on inflammatory cytokines in the synovial fluid of the knee joint of patients with KOA, and explore the effects of PRP intra-articular injection on the inflammation of the knee joint environment and the possible mechanism of action. Methods: Seventy patients were randomized to undergo three blinded weekly intra-articular injections of PRP or hyaluronic acid (HA). The concentrations of inflammatory cytokines, including interleukin (IL)-6, IL-1ß, tumor necrosis factor (TNF)-α, IL-8, IL-17A, IL-17F, IL-4, IL-5, and IL-10, in the synovial fluid were evaluated before the intervention and 1 month after the third injection. The Western Ontario and McMaster University (WOMAC) and visual analog scale (VAS) scores were used to assess pain and functional status of the knee joints in both groups before the intervention, immediately post-intervention, and 1, 3, 6, and 12 months after the intervention. Results: Baseline characteristics were similar in both groups with no statistical difference. The IL-6, IL-1ß, TNF-α, IL-17A, and IL-10 levels in the synovial fluid of the observation group decreased significantly after, vs. before, the intervention (p < 0.05), whereas the IL-8, IL-17F, and IL-4 levels decreased (p > 0.05) and IL-5 levels increased (p > 0.05). There was no statistically significant difference between inflammatory cytokine levels in the synovial fluid of the samples from the control group before and after the intervention (p > 0.05). There were no statistically significant differences between the two groups immediately after intervention (p > 0.05). At 1, 3, 6, and 12 months after intervention, the WOMAC and VAS scores were significantly better in the observation group than in the control group (p < 0.05). Conclusion: Platelet plasma therapy can reduce the concentrations of inflammatory cytokines IL-6, IL-1ß, TNF-α, IL-17A, and IL-10 in the synovial fluid of KOA patients, reduce the expression levels of IL-8, IL-17F, and IL-4, clear the pro-inflammatory factors, improve the inflammatory environment of the affected knee joint, and alleviate pain caused by inflammation. Thus, alleviating pain and improving knee function in patients with KOA.
ABSTRACT
Post-stroke cognitive impairment (PSCI) is a common symptom following brain stroke, yet the mechanisms remain unknown. This study aimed to investigate alterations of static and dynamic functional network connectivity (sFNC and dFNC) in PSCI patients. We prospectively recruited 17 PSCI patients and 24 Healthy controls (HC). Restingstate fMRI (rs-fMRI) and Mini-Mental State Examination (MMSE) were performed. Independent component analysis combined with sliding-window and K-means clustering approach were applied to examine the FNC among 11 resting-state networks: auditory network (AUDN), left executive control network (lECN), language network (LN), precuneus network (PCUN), right executive control network (rECN), salience network (SN), visuospatial network (VN), dorsal default mode network (dDMN), higher visual network (hVIS), primary visual network (pVIS), and ventral mode network (vDMN). The FNC and dynamic indices (fraction time, mean dwell time, transition number) were calculated. Static and dynamic measures were compared between two groups and the correlation between clinical and imaging indicators was analyzed. For sFNC, PSCI group showed decreased interactions in dDMN-vDMN, vDMN-SN, dDMN-hVIS, AUDN-rECN, and AUDN-VN. For dFNC, we derived 3 states of FNC that occurred repeatedly. Significant group differences were found, including decreased interactions in the AUDN-VN, AUDN-pVIS in state 2 and dDMN-VN in state 3. The mean dwell time in PSCI group was longer in state 1, and negatively correlated with MMSE score. These results demonstrated that PSCI patients are characterized with altered sFNC and dFNC, which could help us explore the neural mechanisms of the PSCI from a new perspective.
